journal
https://read.qxmd.com/read/38031892/reduction-in-retinal-microvascular-perfusion-during-migraine-attacks
#1
JOURNAL ARTICLE
Katherine Podraza, Nitin Bangera, Akira Feliz, Andrew Charles
OBJECTIVE: To determine if there are changes in structure and function of the retinal vasculature during and between migraine attacks using optical coherence tomography angiography (OCTA). BACKGROUND: Migraine attacks commonly include visual symptoms, but the potential role of the retina in these symptoms is not well understood. OCTA is a rapid, non-invasive imaging technique that is used to visualize the retinal microvasculature with high spatial resolution in a clinical setting...
November 30, 2023: Headache
https://read.qxmd.com/read/38017629/effect-of-galcanezumab-in-women-with-episodic-migraine-meeting-criteria-for-menstrually-related-migraine-a-post-hoc-analysis-of-evolve-1-and-evolve-2
#2
JOURNAL ARTICLE
E Anne MacGregor, Rose Okonkwo, Holland C Detke, Pepa Polavieja, Maria S Fernandes, Jelena M Pavlovic
BACKGROUND: We evaluated galcanezumab for migraine prevention in patients who met International Classification of Headache Disorders, 3rd edition criteria for menstrually related migraine (MRM). METHODS: Patients were identified post hoc from three double-blind, randomized, phase 3 clinical trials in patients with episodic migraine. Patients completed a 1-month prospective baseline period and up to 6 months (EVOLVE-1 and -2, studies pooled) of double-blind treatment with galcanezumab (120 mg/month) or placebo...
November 28, 2023: Headache
https://read.qxmd.com/read/38009371/ninds-common-data-elements-for-post-traumatic-headache-a-project-from-the-american-headache-society-post-traumatic-headache-special-interest-section
#3
EDITORIAL
Catherine D Chong, Sait Ashina, Joshua Kamins, Ann Scher, Carlyn Patterson Genile, Alan Finkel, Michael L Oshinsky, Todd J Schwedt
No abstract text is available yet for this article.
November 27, 2023: Headache
https://read.qxmd.com/read/37975482/patient-headache-questionnaires-can-improve-headache-diagnosis-and-treatment-in-children
#4
JOURNAL ARTICLE
Christina L Szperka, Stephanie Witzman, Svetlana Ostapenko, John T Farrar, Jesse Yenchih Hsu, Carrie P Malavolta, Janille D Bunney, Erin M Bange, Carlyn Patterson Gentile, Gerardo Velasquez, Blanca Marquez de Prado, Mahgenn Cosico, Meyeon Lee, Pamela Pojomovsky McDonnell, Marisa S Prelack, Madeline A Chadehumbe, Donna J Stephenson, Elizabeth A Kichula, Scott C Tomaine, Andrew D Hershey
OBJECTIVE: To examine trends in diagnosis of headache and migraine in a large pediatric neurology cohort, and test whether an electronic health record (EHR)-integrated headache questionnaire can increase specificity of diagnosis and likelihood of prescribing migraine treatment. BACKGROUND: Under-diagnosis of migraine contributes to the burden of disease. As we founded our Pediatric Headache Program in 2013, we recognized that the proportion of patients with headache who were given a diagnosis of migraine was much lower than expected...
November 17, 2023: Headache
https://read.qxmd.com/read/37964612/headache-launches-the-publication-of-plain-language-summaries
#5
EDITORIAL
Jenn Vallimont, Robert C Gibler, Amy A Gelfand
No abstract text is available yet for this article.
November 14, 2023: Headache
https://read.qxmd.com/read/37964608/patient-headache-questionnaires-can-improve-headache-diagnosis-and-treatment-in-children
#6
JOURNAL ARTICLE
Christina L Szperka
No abstract text is available yet for this article.
November 14, 2023: Headache
https://read.qxmd.com/read/37955395/numbers-needed-to-treat-or-harm-and-likelihood-of-being-helped-versus-harmed-for-fremanezumab-in-patients-who-had-prior-inadequate-response-to-two-to-four-classes-of-migraine-preventive-medications-a-post-hoc-analysis
#7
JOURNAL ARTICLE
Messoud Ashina, Dimos D Mitsikostas, Verena Ramirez Campos, Steve Barash, Xiaoping Ning, Hans-Christoph Diener
OBJECTIVE: This study aimed to determine the number needed to treat (NNT), number needed to harm (NNH), and likelihood of being helped or harmed (LHH) in a post hoc analysis of the phase 3b FOCUS trial. BACKGROUND: Fremanezumab, a humanized monoclonal antibody that selectively targets calcitonin gene-related peptide (CGRP), has demonstrated efficacy, tolerability, and safety in adults with episodic migraine (EM) or chronic migraine (CM), with documented previous inadequate response to two to four classes of migraine preventive medications...
November 13, 2023: Headache
https://read.qxmd.com/read/37938023/association-between-secondhand-smoke-exposure-and-severe-headaches-or-migraine-in-never-smoking-adults
#8
JOURNAL ARTICLE
Junpeng Wu, Panpan Yang, Xiaodan Wu, Xiaoxuan Yu, Fanfang Zeng, Haitang Wang
OBJECTIVE: The study aimed to examine the relationship between secondhand smoke (SHS) exposure and severe headaches or migraine in never-smoking adults verified by serum cotinine. BACKGROUND: Current evidence about the association between self-reported SHS exposure and headaches or migraine is limited and contradictory. An important issue lies in the lack of actual SHS exposure assessment through biomarkers. METHODS: We conducted a cross-sectional study on 4560 never-smoking adults from the National Health and Nutrition Examination Survey (NHANES), 1999-2004...
November 8, 2023: Headache
https://read.qxmd.com/read/37937890/trainee-highlights
#9
EDITORIAL
Sarah M Bobker
No abstract text is available yet for this article.
November 8, 2023: Headache
https://read.qxmd.com/read/37933777/a-qualitative-study-on-the-long-term-effectiveness-of-occipital-nerve-stimulation-in-patients-with-chronic-cluster-headache
#10
JOURNAL ARTICLE
E Kurt, R W Volkers, Y Engels, W M Mulleners, R L Witkam, R T M van Dongen
No abstract text is available yet for this article.
November 7, 2023: Headache
https://read.qxmd.com/read/37882379/the-introduction-of-the-cgrp-monoclonal-antibodies-and-their-effect-on-the-prescription-patterns-of-chronic-migraine-preventive-medications-in-a-tertiary-headache-center-a-retrospective-observational-analysis
#11
JOURNAL ARTICLE
Leon S Moskatel, Anna Graber-Naidich, Zihuai He, Niushen Zhang
OBJECTIVE: To determine the effect of the introduction of the calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) in 2018 on the prescribing of older medications for the prevention of chronic migraine. BACKGROUND: Prior to 2018, the preventive treatment of migraine borrowed from medications intended to treat other illnesses with the last medication, onabotulinumtoxinA, receiving Food and Drug Administration (FDA) approval for the prevention of chronic migraine in 2010...
October 26, 2023: Headache
https://read.qxmd.com/read/37882325/understanding-the-links-between-airborne-hazards-and-headache-disorders
#12
EDITORIAL
Elizabeth K Seng, Andrea H Weinberger
No abstract text is available yet for this article.
October 26, 2023: Headache
https://read.qxmd.com/read/37873980/caution-regarding-fabricated-citations-from-artificial-intelligence
#13
EDITORIAL
Fred Cohen, Jenn Vallimont, Amy A Gelfand
No abstract text is available yet for this article.
October 24, 2023: Headache
https://read.qxmd.com/read/37873975/hypermobility-spectrum-disorders-and-migraine-in-adolescents
#14
EDITORIAL
Chia-Chun Chiang
No abstract text is available yet for this article.
October 24, 2023: Headache
https://read.qxmd.com/read/37873925/evaluating-therapeutic-benefits-of-ubrogepant-via-latent-class-models-a-post-hoc-exploratory-analysis-of-the-achieve-i-and-achieve-ii-trials
#15
JOURNAL ARTICLE
Charlie J Iaconangelo, Daniel Serrano, Aubrey Manack Adams, Joel M Trugman, Richard B Lipton
OBJECTIVE: To evaluate an alternative method of defining acute treatment success in migraine by combining multiple indicators into a single dichotomous measure of success. BACKGROUND: Migraine is characterized by a symptom complex; combining these features as a single endpoint may improve the measurement of treatment effects and better predict patient satisfaction with treatment. METHODS: We used a confirmatory latent class model (LCM) with two latent classes interpreted as treatment success and treatment failure...
October 24, 2023: Headache
https://read.qxmd.com/read/37837216/comparative-prevalence-and-characteristics-of-fabricated-citations-in-large-language-models-in-headache-medicine
#16
JOURNAL ARTICLE
Leon S Moskatel, Niushen Zhang
No abstract text is available yet for this article.
October 14, 2023: Headache
https://read.qxmd.com/read/37830925/patterns-of-anti-cgrp-mabs-use-and-variation-of-triptan-consumption-following-treatment-initiation-a-descriptive-drug-utilization-study-in-the-tuscany-region-italy
#17
JOURNAL ARTICLE
Giulia Hyeraci, Olga Paoletti, Luigi Francesco Iannone, Rosa Gini, Francesco De Cesaris, Pierangelo Geppetti, Giuseppe Roberto
OBJECTIVE: To describe the pattern of anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) utilization in the Tuscany region, Italy, and the variation of triptan consumption after treatment initiation. BACKGROUND: Given the recent commercialization of anti-CGRP mAbs as migraine preventive medications, real-world evidence on their patterns of utilization and their impact on migraine abortive medication use is still limited. METHODS: A retrospective, descriptive, cohort study on the real-world utilization of anti-CGRP mAbs was performed using the population-based regional administrative database of Tuscany...
October 13, 2023: Headache
https://read.qxmd.com/read/37796114/plasma-calcitonin-gene-related-peptide-and-nerve-growth-factor-as-headache-and-pain-biomarkers-in-recently-deployed-soldiers-with-and-without-a-recent-concussion
#18
JOURNAL ARTICLE
Ann I Scher, James S McGinley, Lyndsey R VanDam, Amanda M Campbell, Xiyun Chai, Billy Collins, Scott A Klimp, Alan G Finkel, Karen Schwab, Richard B Lipton, Kirk W Johnson
OBJECTIVE: The objective of this study was to characterize the utility of calcitonin gene-related peptide (CGRP) and nerve growth factor (NGF) as potential biomarkers for headache and pain disorders in the post-military deployment setting. BACKGROUND: The need to improve recognition, assessment, and prognoses of individuals with posttraumatic headache or other pain has increased interest in the potential of CGRP and NGF as biomarkers. METHODS: The Warrior Strong Study (NCT01847040) is an observational longitudinal study of United States-based soldiers who had recently returned from deployment to Afghanistan or Iraq from 2009 to 2014...
October 5, 2023: Headache
https://read.qxmd.com/read/37796087/effects-of-caffeine-on-intracranial-pressure-and-pain-perception-in-freely-moving-rats
#19
JOURNAL ARTICLE
Ida Marchen Egerod Israelsen, Connar Stanley James Westgate, Christina Kamp-Jensen, Rigmor H Jensen, Sajedeh Eftekhari
OBJECTIVE: Caffeine, a non-selective adenosine receptor (AR) antagonist, is the most consumed psychostimulant in the world. Caffeine has been suggested to regulate cerebrospinal fluid secretion and is known both to alleviate and to trigger headache; however, its effect on the regulation of intracranial pressure (ICP) is not known. Therefore, we aimed to investigate the effects of caffeine on ICP and nociceptive responses. METHODS: Female Sprague-Dawley rats were implanted with a novel telemetric device for continuous ICP recordings, which allowed for continuous recordings in freely moving rats...
October 5, 2023: Headache
https://read.qxmd.com/read/37795754/migraine-and-air-pollution-a-systematic-review
#20
REVIEW
Andrea E Portt, Christa Orchard, Hong Chen, Erjia Ge, Christine Lay, Peter M Smith
OBJECTIVE: To systematically synthesize evidence from a broad range of studies on the association between air pollution and migraine. BACKGROUND: Air pollution is a ubiquitous exposure that may trigger migraine attacks. There has been no systematic review of this possible association. METHODS: We searched for empirical studies assessing outdoor air pollution and any quantified migraine outcomes. We included short- and long-term studies with quantified air pollution exposures...
October 5, 2023: Headache
journal
journal
25525
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.